CN101066975B - Europium complex with visible light sensitized light emitting performance and its synthesis process - Google Patents

Europium complex with visible light sensitized light emitting performance and its synthesis process Download PDF

Info

Publication number
CN101066975B
CN101066975B CN2007101189773A CN200710118977A CN101066975B CN 101066975 B CN101066975 B CN 101066975B CN 2007101189773 A CN2007101189773 A CN 2007101189773A CN 200710118977 A CN200710118977 A CN 200710118977A CN 101066975 B CN101066975 B CN 101066975B
Authority
CN
China
Prior art keywords
formula
europium complex
suc
compound
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2007101189773A
Other languages
Chinese (zh)
Other versions
CN101066975A (en
Inventor
王远
郝锐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing nano material technology Co., Ltd.
Original Assignee
Peking University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peking University filed Critical Peking University
Priority to CN2007101189773A priority Critical patent/CN101066975B/en
Publication of CN101066975A publication Critical patent/CN101066975A/en
Priority to PCT/CN2008/000945 priority patent/WO2008154798A1/en
Application granted granted Critical
Publication of CN101066975B publication Critical patent/CN101066975B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Abstract

The present invention discloses one kind of europium complex with visible light sensitized light emitting performance and its synthesis process. The europium complex of the present invention as one REcomplex has structure as shown. The europium complex has excellent visible light sensitized light emitting performance, and may be applied in synthesizing biological fluorescent probe and other functional materials with excellent light emitting performance and possesses important application in biosensing, imaging, fluoresce immunoassay, etc.

Description

Europium complex and synthetic method thereof with visible light sensitized light emitting performance
Technical field
The present invention relates to a kind of europium complex and synthetic method thereof with visible light sensitized light emitting performance.
Background technology
The distinct electrical minor structure of rare earth ion makes its compound have many special spectral qualities.They have significant application value at aspects such as luminescent device (electricity-saving lamp, photodiode, indicating meter), optical fiber, optical amplifier, laser, bio-sensing, bio-imaging and fluoroimmunoassays.Rare earth ion can reduce the fluorescence interference that biomaterial itself produces in the sharp line emission and the long luminous attitude life-span (ms level) of visible or near-infrared region, make to detect to have very high sensitivity and efficient, avoided a series of problems of using radioelement to bring simultaneously.
Because the f-f transition of rare earth ion is subjected to eelctric dipole to select the restriction of rate, the light absorpting ability of rare earth ion itself is very weak, molar extinction coefficient is very little, therefore to obtain luminescent properties preferably, need carry out sensitization to rare earth ion, promptly pass through part (or charge transfer state) extinction, and make energy be transferred to the rare earth luminescence attitude to realize the efficiently luminous of rare earth ion as sensitizing agent.Though many rare earth compoundings are under ultraviolet excitation, show luminescent properties preferably, but UV-light is to the organism damage and disturb bigger, also can produce stronger background fluorescence, therefore, become one of important research direction (K.Kuningas to the luminous efficiency that excites window and improve rare earth compounding of long wave direction expansion rare earth compounding, et al., Anal.Chem.2005,77,7348).WO2003076938-A has reported the two class rare earth ion title complexs that contain terpyridyl structured light sensitization part and two pyrazoles-pyridine structure photosensitization part.Wherein with N, N, N ', N '-[(4 '-(5 ' " amino-2 ' "-thienyl)-2,2 ': 6 ', 2 " terpyridyls-6,6 ", two bases) two (methylene radical itrile groups)] acetate (N, N, N ', N '-[(4 '-(5 ' " amino-2 ' "-thienyl)-2,2 ': 6 ', 2 " terpyridine-6,6 " diyl) bis (methylenenitrilo)] tetrakis (acetate)) as the Eu of sensitization part 3+The peak value of the excitation spectrum of title complex appears at the 336nm place, and it excites the window afterbody to extend to 410nm, and fluorescence quantum yield is 0.15.In recent years, the present inventor designs, has synthesized a kind of novel rare-earth title complex [Eu (tta) 3Dpbt] (tta is the thenoyltrifluoroacetone negative ion for dpbt=2-(N, N-Diethyl Aniline-4-yl)-4,6-two (3-1-yl)-1,3,5-triazines).(concentration is 10 to be dissolved in this title complex in the toluene -5The dilute solution of M) the window that excites can extend to 441nm, and this title complex has very high luminescent quantum productive rate (0.52) (Y.Wang, et al., Angew.Chem.Int.Ed.2004,43,5010).If with this type of rare earth compounding fluorescence dye serves as that basis preparation biological fluorescent labeling is applied to fluoroimmunoassay, the employing longwave optical excites, and will make advantages such as fluoroimmunoassay has highly sensitive, high s/n ratio concurrently, penetration depth is big, little with interference to the organism damage, analysis cost is low.
Create the novel rare-earth complex luminescent material, make it as seen to send out and excite and have bigger rare-earth fluorescent quantum yield (Φ) and luminous power down that (Φ * ε) has important application value at long wave.
The present inventor has synthesized a class photosensitive molecular part, and its structure is suc as formula shown in the II: its synthetic method may further comprise the steps:
Structure suc as formula compound shown in a and three polychlorostyrene piperazines (cyanuryl chloride, cyanuric chloride) reaction, with pyrazoles negative ion shown in gained reaction product and the formula b or the reaction of substituted pyrazolecarboxylic negative ion, is made the photosensitive organic molecule ligand shown in the formula II;
Figure G2007101189773D00022
Formula a, formula c, R among the formula II 1, R 2For carbonatoms is the alkyl of 1-4, R 3, R 4Be methyl or H; X is haloid elements such as I, Br, Cl; R among the formula b 5=R 7Be methyl or H; R among the formula II 5=R 6=R 7=R 8Be methyl or H.
Wherein, structure is that compound shown in the formula c and lithium alkylide are reacted prepared product suc as formula the compound shown in a; The carbonatoms of wherein said lithium alkylide is 1-8.
Summary of the invention
The purpose of this invention is to provide a kind of europium complex and synthetic method thereof with visible light sensitized light emitting performance.
Europium complex provided by the present invention, its structure be suc as formula shown in the I, wherein R 1, R 2Be that carbonatoms is 1 to 4 alkyl, R 3, R 4Be methyl or H, R 5=R 6=R 7=R 8Be methyl or H; Be preferably R among the described formula I 1=R 2=ethyl, R 3=R 4=H, R 5=R 6=R 7=R 8=methyl.
Figure G2007101189773D00023
Synthetic method with europium complex of visible light sensitized light emitting performance provided by the present invention is with the compound reaction of structure suc as formula compound and structure such as the formula III of II, obtains the Photostimulable luminescence europium complex of described structure suc as formula I.
Figure G2007101189773D00031
R among its Chinese style II 1, R 2Be that carbonatoms is 1 to 4 alkyl, R 3, R 4Be methyl or H, R 5=R 6=R 7=R 8Be methyl or H.
In the described method, the mol ratio of described structural formula compound reaction shown in formula III suc as formula compound shown in the II and structural formula is 1: 1.
In the described method, described structural formula suc as formula the temperature of compound shown in the II and the structural formula compound reaction shown in formula III is-10-100 ℃.
In the described method, described reaction is all carried out in organic solvent, and described organic solvent is one or more in tetrahydrofuran (THF), ether, benzene,toluene,xylene, chloroform and the methylene dichloride.
Structure provided by the present invention has very high rare-earth fluorescent quantum yield suc as formula the europium complex shown in the I under excited by visible light.In formula I, R 1=R 2=H 3CH 2C-, R 3=R 4=H, R 5=R 6=R 7=R 8=H 3The europium complex IV of C-is an example, its Eu 3+Fluorescence quantum yield is up to 0.94 (λ Ex=411nm), far above being seen in so far in other visible light sensitized light emitting rare-earth luminescent material of report.The peak value of this europium complex excitation spectrum is at the 403nm place, and afterbody is extended to 441nm, and (concentration is 1.0 * 10 -5M).Under natural light irradiation, this europium complex that not only is dissolved in the toluene can send pure ruddiness, and its solid also can send stronger ruddiness.This compound is the strongest rare earth compounding of visible light sensitized light emitting ability up to now.Other structure also has good visible light sensitized light emitting performance suc as formula the europium complex shown in the I.In a word, rare earth compounding of the present invention has the excellent visible light sensitized light emitting performance, can be used for the functional materialss such as biological fluorescent labeling of synthetic luminescent properties excellence, have significant application value and bright prospects at aspects such as bio-sensing, imaging and fluoroimmunoassays.
Description of drawings
Fig. 1 is the fluorescence excitation spectrogram (λ of the europium complex shown in the formula IV of the present invention Em=614nm);
Fig. 2 is the fluorescent emission spectrogram (λ of the europium complex shown in the formula IV of the present invention Ex=411nm);
Fig. 3 is the europium complex shown in the formula IV of the present invention 1H NMR figure.
Embodiment
In order to be described more specifically the present invention, now provide some embodiment.But content involved in the present invention is not limited only to these examples.Method among the following embodiment if no special instructions, is ordinary method.Used raw material all can be commercially available in reaction.
A class of the present invention has the synthetic method of the europium complex of visible light sensitized light emitting performance, and its reaction process is as described below:
Figure G2007101189773D00041
Its Chinese style I, the R among the formula II 1, R 2Be that carbonatoms is 1 to 4 alkyl, R 3, R 4Be methyl or H, R 5=R 6=R 7=R 8Be methyl or H.
The synthetic method of europium complex of the present invention, its concrete steps are as described below:
The compound of structure such as formula III and the structure compound suc as formula II is reacted in organic solution, obtain structure suc as formula the described Photostimulable luminescence europium complex of I.
Above-mentioned reaction can be carried out in many organic solvents, ether solvent such as tetrahydrofuran (THF), ether for example, aromatic solvents such as benzene,toluene,xylene, chlorinated solvent such as chloroform, methylene dichloride.
With following embodiment is example, specifies the synthetic method and the effect thereof of the europium complex shown in the above-mentioned formula I.
Embodiment 1, composite structure formula (are R among the formula I suc as formula the europium complex shown in the IV 1=R 2==H 3CH 2C-, R 3=R 4=H, R 5=R 6=R 7=R 8=H 3C-)
Get N; N-diethyl para-bromoaniline 4mmol is dissolved in the dry tetrahydrofuran (THF) of crossing logical argon gas deoxygenation; place-78 ℃ dry ice acetone bath; under argon shield, add 6.4mmol n-BuLi, slowly be warming up to room temperature after; continue to stir 30min; its adding is frozen among the three polychlorostyrene piperazine 5.4mmol under-78 ℃, slowly be warming up to room temperature after, continue to stir 60min.Except that after desolvating, product separates with silica gel column chromatography, and eluent is a methylene dichloride.With the thick product of gained recrystallization in sherwood oil, obtain 2-(N, N-Diethyl Aniline-4-yl)-4, the yellow needle-like crystal 0.65g of 6-two chloro-1,3,5-triazines.Under argon shield, the potassium metal 1.25mmol that newly cuts is added in the anhydrous tetrahydro furan; Add 3 1.75mmol, reflux 3h generates the 3 negative ion; Reaction mixture is placed ice bath, to wherein adding 2-(N, N-Diethyl Aniline-4-yl)-4,6-two chloro-1,3,5-triazines 0.5mmol, stirring at room 1h, back flow reaction 8-9h in 80-85 ℃ oil bath then.The cooling back concentrates, and makes eluent with the mixed solution (volume ratio of methylene dichloride and ethyl acetate is 3: 1) of methylene dichloride and ethyl acetate, separates by silica gel column chromatography.The gained crude product gets structure suc as formula (R shown in the II with mixed solution (volume ratio of sherwood oil and methylene dichloride is 1: the 1) recrystallization of sherwood oil and methylene dichloride 1=R 2=H 3CH 2C-, R 3=R 4=H, R 5=R 6=R 7=R 8=H 3The yellow needle-like crystal 0.18g of ligand molecular C-).
Get in the tetrahydrofuran (THF) that the compound 0.05mmol of structure shown in formula III be dissolved in 30mL and make solution A, get structure suc as formula (R shown in the II 1=R 2=H 3CH 2C-, R 3=R 4=H, R 5=R 6=R 7=R 8=H 3C-) ligand compound 0.05mmol is dissolved in the 30mL tetrahydrofuran (THF) and makes Solution H, and solution A is dropwise added in the Solution H.25 ℃ are stirred 1h, and the evaporated under reduced pressure solvent gets the orange/yellow solid 72.7mg of structure suc as formula IV.
The above-mentioned orange/yellow solid that obtains is carried out mass spectrum (MALDI-TOF MS) analysis, record molecular ion peak M/Z=1454; Ultimate analysis (quality percentage composition): C, 43.66% (43.78%); H, 4.38% (4.02%); N, 7.43% (7.71%), in the bracket theoretical value; It is the europium complex shown in the formula IV that nuclear magnetic resonance spectrum characterizes the above-mentioned orange/yellow solid product of proof, its 1H NMR spectrum as shown in Figure 3.
Fluorescence excitation spectrum (the λ of the europium complex shown in the formula IV Em=614nm) as shown in Figure 1; Fluorescence emission spectrum (the λ of this title complex Ex=411nm) as shown in Figure 2.The result of Fig. 1-2 shows that europium complex provided by the present invention has the excellent visible light sensitized light emitting performance.Dimethyl sulfoxide solution with 4-dicyanomethylene-2-methyl-6-p-dimethylaminostyrl-4H-py ran (DCM) is reference substance (Φ=0.8, J.M.Drake, et.al., Chem.Phys.Lett.1985,113,530-534.), at wavelength is under the 411nm excitation light irradiation, the europium ion fluorescence quantum yield that records the europium complex shown in the formula IV is 0.94 (the detection wavelength is 614nm), and this quantum yield is far above the rare-earth fluorescent quantum yield of other known visible light sensitized light emitting europium complex.
Figure G2007101189773D00051
Europium complex shown in embodiment 2, the synthesis type V (is R among the formula I 1=R 2=H 3C-, R 3=R 4=H, R 5=R 6=R 7=R 8=H 3C-)
According to the synthetic method of embodiment 1, use N, the N-dimethylated replaces N, and N-diethyl para-bromoaniline syntheticly obtains structure suc as formula (R shown in the II 1=R 2=H 3C-, R 3=R 4=H, R 5=R 6=R 7=R 8=H 3C-) ligand compound.
Get in the tetrahydrofuran (THF) that the compound 0.05mmol of structure shown in formula III be dissolved in 30mL and make solution A, get structure suc as formula (R shown in the II 1=R 2=H 3C-, R 3=R 4=H, R 5=R 6=R 7=R 8=H 3C-) ligand compound 0.05mmol is dissolved in the 30mL tetrahydrofuran (THF) and makes solution I, and solution A is dropwise added in the solution I.Behind 25 ℃ of stirring 1h, the evaporated under reduced pressure solvent gets the orange/yellow solid 71.3mg of structure suc as formula V.
The above-mentioned orange/yellow solid that obtains is carried out mass spectrum (MALDI-TOF MS) analysis, record molecular ion peak M/Z=1426; Ultimate analysis (quality percentage composition): C, 43.29% (42.96%); H, 3.77% (3.82%); N, 7.65% (7.86%), in the bracket theoretical value; The structural formula that nuclear magnetic resonance spectrum characterizes proof orange/yellow solid product is formula V.
According to the method for embodiment 1, be under the 411nm excitation light irradiation at wavelength, recording structure is 0.90 (the detection wavelength is 614nm) suc as formula the europium ion fluorescence quantum yield of the europium complex of V.
Figure G2007101189773D00061
Title complex shown in embodiment 3, the synthesis type VI (is R among the formula I 1=R 2=n-H 9C 4-, R 3=R 4=H, R 5=R 6=R 7=R 8=H 3C-)
According to the synthetic method of embodiment 1, use N, N-dibutyl para-bromoaniline replaces N, and N-diethyl para-bromoaniline syntheticly obtains structure suc as formula (R shown in the II 1=R 2=n-H 9C 4-, R 3=R 4=H, R 5=R 6=R 7=R 8=H 3C-) ligand compound.
Get in the ether that the compound 0.05mmol of structure shown in formula III be dissolved in 30mL and make solution B, get structure suc as formula (R shown in the II 1=R 2=n-H 9C 4-, R 3=R 4=H, R 5=R 6=R 7=R 8=H 3C-) ligand compound 0.05mmol is dissolved in and makes solution J in the 30mL ether, and solution B is dropwise added among the solution J.Behind 25 ℃ of stirring 1h, the evaporated under reduced pressure solvent gets the orange/yellow solid 75.5mg of structure suc as formula VI.
The above-mentioned orange/yellow solid that obtains is carried out mass spectrum (MALDI-TOF MS) analysis, record molecular ion peak M/Z=1510; Ultimate analysis (quality percentage composition): C, 45.66% (45.34%); H, 4.22% (4.41%); N, 7.33% (7.42%), in the bracket theoretical value; The structural formula that nuclear magnetic resonance spectrum characterizes the above-mentioned orange/yellow solid product of proof is formula VI.
According to the method for embodiment 1, be under the 411nm excitation light irradiation at wavelength, the europium ion fluorescence quantum yield that records formula VI europium complex is 0.87 (the detection wavelength is 614nm).
Figure G2007101189773D00071
Europium complex shown in embodiment 4, the synthesis type VII (is R among the formula I 1=R 2=H 3CH 2C-, R 3=R 4=R 5=R 6=R 7=R 8=H 3C-)
Get N, N-diethyl-2,6-dimethyl-para-bromoaniline 4mmol; be dissolved in the dry tetrahydrofuran (THF) of crossing; logical argon gas deoxygenation places-78 ℃ dry ice acetone bath, under argon shield; add 6.4mmol n-BuLi; after slowly being warming up to room temperature, continue to stir 30min, its adding is frozen among the three polychlorostyrene piperazine 5.4mmol under-78 ℃; after slowly being warming up to room temperature, continue to stir 60min.Except that after desolvating, product separates with silica gel column chromatography, and eluent is a methylene dichloride.With the thick product of gained recrystallization in sherwood oil, obtain 2-(N, N-diethyl-2,6-xylidine-4-yl)-4, the yellow needle-like crystal 0.65g of 6-two chloro-1,3,5-triazines.Under argon shield, the potassium metal 1.25mmol that newly cuts is added in the anhydrous tetrahydro furan; Add 3 1.75mmol, reflux 3h generates the 3 negative ion; Reaction mixture is placed ice bath, to wherein adding 2-(N, N-diethyl-2,6-xylidine-4-yl)-4,6-two chloro-1,3,5-triazines 0.5mmol, stirring at room 1h, back flow reaction 8-9h in 80-85 ℃ oil bath then.The cooling back concentrates, and makes eluent with the mixed solution (volume ratio of methylene dichloride and ethyl acetate is 3: 1) of methylene dichloride and ethyl acetate, separates by silica gel column chromatography.The gained crude product gets structure suc as formula (R shown in the II with mixed solution (volume ratio of sherwood oil and methylene dichloride is 1: the 1) recrystallization of sherwood oil and methylene dichloride 1=R 2=H 3CH 2C-, R 3=R 4=R 5=R 6=R 7=R 8=H 3The yellow needle-like crystal 90mg of ligand molecular C-).
Get in the chloroform that the compound 0.05mmol of structure shown in formula III be dissolved in 30mL and make solution C, get structure suc as formula (R shown in the II 1=R 2=H 3CH 2C-, R 3=R 4=R 5=R 6=R 7=R 8=H 3C-) ligand compound 0.05mmol is dissolved in and makes solution K in the 30mL chloroform, and solution C is dropwise added among the solution K.After stirring 1h under-10 ℃, the evaporated under reduced pressure solvent gets the orange/yellow solid 74.1mg of structure suc as formula VII.
The above-mentioned orange/yellow solid that obtains is carried out mass spectrum (MALDI-TOF MS) analysis, record molecular ion peak M/Z=1482; Ultimate analysis (quality percentage composition): C, 44.70% (44.57%); H, 4.19% (4.22%); N, 7.47% (7.56%), in the bracket theoretical value; The structural formula that nuclear magnetic resonance spectrum characterizes the above-mentioned product of proof is formula VII.
According to the method for embodiment 1, be under the 411nm excitation light irradiation at wavelength, the europium ion fluorescence quantum yield that records the europium complex shown in the formula VII is 0.93 (the detection wavelength is 614nm).
Figure G2007101189773D00081
Europium complex shown in embodiment 5, the synthesis type VIII (is R among the formula I 1=R 2=R 3=R 4=R 5=R 6=R 7=R 8=H 3C-)
According to the synthetic method of embodiment 4, use N, N-dimethyl-2,6-dimethyl-para-bromoaniline replaces N, N-diethyl-2,6-dimethyl-para-bromoaniline syntheticly obtains structure suc as formula (R shown in the II 1=R 2=R 3=R 4=R 5=R 6=R 7=R 8=H 3C-) ligand compound.
Get in the toluene that the compound 0.05mmol of structure shown in formula III be dissolved in 30mL and make solution D, get structure suc as formula (R shown in the II 1=R 2=R 3=R 4=R 5=R 6=R 7=R 8=H 3C-) ligand compound 0.05mmol is dissolved in and makes solution L in the 30mL toluene, and solution D is dropwise added among the solution L.Under argon shield, behind 100 ℃ of stirring 1h, the evaporated under reduced pressure solvent gets the orange/yellow solid 72.7mg of structure suc as formula VIII.
The above-mentioned orange/yellow solid that obtains is carried out mass spectrum (MALDI-TOF MS) analysis, record molecular ion peak M/Z=1454; Ultimate analysis (quality percentage composition): C, 43.67% (43.78%); H, 4.04% (4.02%); N, 7.79% (7.71%), in the bracket theoretical value; The structural formula that nuclear magnetic resonance spectrum characterizes the above-mentioned orange/yellow solid product that obtains of proof is formula VIII.
According to the method for embodiment 1, be under the 411nm excitation light irradiation at wavelength, the europium ion fluorescence quantum yield that records formula VIII europium complex is 0.85 (the detection wavelength is 614nm).
Figure G2007101189773D00082
Europium complex shown in embodiment 6, the synthesis type IX (is R among the formula I 1=R 2=n-H 9C 4-, R 3=R 4=R 5=R 6=R 7=R 8=H 3C-)
According to the synthetic method of embodiment 4, use N, N-dibutyl-2,6-dimethyl-para-bromoaniline replaces N, N-diethyl-2,6-dimethyl-para-bromoaniline syntheticly obtains structure suc as formula (R shown in the II 1=R 2=n-H 9C 4-, R 3=R 4=R 5=R 6=R 7=R 8=H 3C-) ligand compound.
Get in the benzene that the compound 0.05mmol of structure shown in formula III be dissolved in 30mL and make solution E, get structure suc as formula (R shown in the II 1=R 2=n-H 9C 4-, R 3=R 4=R 5=R 6=R 7=R 8=H 3C-) ligand compound 0.05mmol is dissolved in and makes solution M in the 30mL benzene, and solution E is dropwise added among the solution M.Behind 50 ℃ of stirring 1h, the evaporated under reduced pressure solvent gets the orange/yellow solid 76.9mg of structure suc as formula IX.
The above-mentioned orange/yellow solid that obtains is carried out mass spectrum (MALDI-TOF MS) analysis, record molecular ion peak M/Z=1538; Ultimate analysis (quality percentage composition): C, 45.87% (46.07%); H, 4.72% (4.59%); N, 7.25% (7.28%), in the bracket theoretical value; The structural formula that nuclear magnetic resonance spectrum characterizes the above-mentioned orange/yellow solid product that obtains of proof is formula IX.
According to the method for embodiment 1, be under the 411nm excitation light irradiation at wavelength, the europium ion fluorescence quantum yield that records the europium complex shown in the formula IX is 0.75 (the detection wavelength is 614nm).
Figure G2007101189773D00091
Europium complex shown in embodiment 7, the synthesis type X (is R among the formula I 1=R 2=H 3CH 2C-, R 3=R 4=R 5=R 6=R 7=R 8=H)
Synthetic method according to embodiment 1 replaces 3 with pyrazoles, synthesizes to obtain structure suc as formula (R shown in the II 1=R 2=H 3CH 2C-, R 3=R 4=R 5=R 6=R 7=R 8=H) ligand compound.
Get in the tetrahydrofuran (THF) that the compound 0.05mmol of structure shown in formula III be dissolved in 30mL and make solution A, get structure suc as formula (R shown in the II 1=R 2=H 3CH 2C-, R 3=R 4=R 5=R 6=R 7=R 8=H) ligand compound 0.05mmol is dissolved in and makes solution N in the 30mL tetrahydrofuran (THF), solution A is dropwise added among the solution N.Behind 25 ℃ of stirring 1h, the evaporated under reduced pressure solvent gets the orange/yellow solid 69.8mg of structure suc as formula X.
The above-mentioned orange/yellow solid that obtains is carried out mass spectrum (MALDI-TOF MS) analysis, record molecular ion peak M/Z=1398; Ultimate analysis (quality percentage composition): C, 41.80% (42.10%); H, 3.63% (3.61%); N, 8.21% (8.02%), in the bracket theoretical value; The structural formula that nuclear magnetic resonance spectrum characterizes the above-mentioned orange/yellow solid that obtains of proof is formula X.
Europium complex shown in embodiment 8, the synthesis type XI (is R among the formula I 1=R 2=H 3CH 2C-, R 3=R 4=H 3C-, R 5=R 6=R 7=R 8=H)
Synthetic method according to embodiment 4 replaces 3 with pyrazoles, synthesizes to obtain structure suc as formula (R shown in the II 1=R 2=H 3CH 2C-, R 3=R 4=H 3C-, R 5=R 6=R 7=R 8=H) ligand compound.
Get in the methylene dichloride that the compound 0.05mmol of structure shown in formula III be dissolved in 30mL and make solution F, get structure suc as formula (R shown in the II 1=R 2=H 3CH 2C-, R 3=R 4=H 3C-, R 5=R 6=R 7=R 8=H) ligand compound 0.05mmol is dissolved in and makes solution P in the 30mL methylene dichloride, solution F is dropwise added among the solution P.Behind 25 ℃ of stirring 1h, the evaporated under reduced pressure solvent gets the orange/yellow solid 71.3mg of structure suc as formula XI.
The above-mentioned orange/yellow solid that obtains is carried out mass spectrum (MALDI-TOF MS) analysis, record molecular ion peak M/Z=1426; Ultimate analysis (quality percentage composition): C, 42.64% (42.96%); H, 3.96% (3.82%); N, 7.99% (7.86%), in the bracket theoretical value; The structural formula that nuclear magnetic resonance spectrum characterizes the above-mentioned orange/yellow solid product that obtains of proof is formula XI.
Figure G2007101189773D00102
Europium complex shown in embodiment 9, the synthesis type XII (is R among the formula I 1=H 3C-, R 2=n-H 9C 4-, R 3=R 4=R 5=R 6=R 7=R 8=H 3C-)
According to the synthetic method of embodiment 4, with N-methyl-N-butyl-2,6-dimethyl-para-bromoaniline replaces N, N-diethyl-2, and 6-dimethyl-para-bromoaniline syntheticly obtains structure suc as formula (R shown in the II 1=H 3C-, R 2=n-H 9C 4-, R 3=R 4=R 5=R 6=R 7=R 8=H 3C-) ligand compound.
Get in the tetrahydrofuran (THF) that the compound 0.05mmol of structure shown in formula III be dissolved in 30mL and make solution A, get structure suc as formula (R shown in the II 1=H 3C-, R 2=n-H 9C 4-, R 3=R 4=R 5=R 6=R 7=R 8=H 3C-) ligand compound 0.05mmol is dissolved in and makes solution Q in the 30mL benzene, and solution A is dropwise added among the solution Q.Behind 50 ℃ of stirring 1h, the evaporated under reduced pressure solvent gets the orange/yellow solid 74.8mg of structure suc as formula XIII.
The above-mentioned orange/yellow solid that obtains is carried out mass spectrum (MALDI-TOF MS) analysis, record molecular ion peak M/Z=1496; Ultimate analysis (quality percentage composition): C, 45.17% (44.96%); H, 4.39% (4.31%); N, 7.34% (7.49%), in the bracket theoretical value; The structural formula that nuclear magnetic resonance spectrum characterizes the above-mentioned orange/yellow solid product that obtains of proof is formula XII.
Europium complex shown in embodiment 10, the synthesis type XIII (is R among the formula I 1=H 3C-, R 2=n-H 9C 4-, R 3=R 4=H, R 5=R 6=R 7=R 8=H 3C-)
According to the synthetic method of embodiment 1, replace N with N-methyl-N-butyl para-bromoaniline, N-diethyl para-bromoaniline syntheticly obtains structure suc as formula (R shown in the II 1=H 3C-, R 2=n-H 9C 4-, R 3=R 4=H, R 5=R 6=R 7=R 8=H 3C-) ligand compound.
Get in the tetrahydrofuran (THF) that the compound 0.05mmol of structure shown in formula III be dissolved in 30mL and make solution A, get structure suc as formula (R shown in the II 1=H 3C-, R 2=n-H 9C 4-, R 3=R 4=H, R 5=R 6=R 7=R 8=H 3C-) ligand molecular 0.05mmol is dissolved in and makes solution R in the 30mL ether, and solution A is dropwise added among the solution R.Behind 25 ℃ of stirring 1h, the evaporated under reduced pressure solvent gets the orange/yellow solid 73.4mg of structure suc as formula XIII.
The above-mentioned orange/yellow solid that obtains is carried out mass spectrum (MALDI-TOF MS) analysis, record molecular ion peak M/Z=1468; Ultimate analysis (quality percentage composition): C, 45.29% (44.18%); H, 4.06% (4.12%); N, 7.61% (7.63%), in the bracket theoretical value; The structural formula that nuclear magnetic resonance spectrum characterizes the above-mentioned orange/yellow solid product that obtains of proof is formula XIII.
Figure G2007101189773D00121
Embodiment 11, synthesis type XIV europium complex (are R among the formula I 1=R 2=H 3CH 2C-, R 3=H, R 4=R 5=R 6=R 7=R 8=H 3C-)
According to the synthetic method of embodiment 4, use N, N-diethyl-2-methyl-para-bromoaniline replaces N, N-diethyl-2,6-dimethyl-para-bromoaniline syntheticly obtains structure suc as formula (R shown in the II 1=R 2=H 3CH 2C-, R 3=H, R 4=R 5=R 6=R 7=R 8=H 3C-) ligand compound.
Get in the tetrahydrofuran (THF) that the compound 0.05mmol of structure shown in formula III be dissolved in 30mL and make solution A, get structure suc as formula (R shown in the II 1=R 2=H 3CH 2C-, R 3=H, R 4=R 5=R 6=R 7=R 8=H 3C-) ligand compound 0.05mmol is dissolved in the 30mL toluene and makes solution S, and solution A is dropwise added in the solution S.Under nitrogen protection, behind 30 ℃ of stirring 1h, the evaporated under reduced pressure solvent gets the orange/yellow solid 73.4mg of structure suc as formula XIV.
The above-mentioned orange/yellow solid that obtains is carried out mass spectrum (MALDI-TOF MS) analysis, record molecular ion peak M/Z=1468; Ultimate analysis (quality percentage composition): C, 45.34% (44.18%); H, 4.09% (4.12%); N, 7.72% (7.63%), in the bracket theoretical value; The structural formula that nuclear magnetic resonance spectrum characterizes the above-mentioned orange/yellow solid product that obtains of proof is formula XIV.
According to the method for embodiment 1, be under the 411nm excitation light irradiation at wavelength, the europium ion fluorescence quantum yield that records the europium complex shown in the formula IX is 0.70 (the detection wavelength is 614nm).
Figure G2007101189773D00122
The foregoing description shows that structure provided by the present invention has the excellent visible light sensitized light emitting performance suc as formula the novel europium complex shown in the I, its visible light photoactivated europium ion fluorescence quantum yield is far above the maximum of having reported at present 0.52, simultaneously europium ion sensitized fluorescence window long wave direction shows that suc as formula the excellent sensitized light emitting performance of the title complex shown in the I it is synthetic at biological fluorescent labeling greater than 440nm. structure provided by the present invention, and fields such as bio-sensing and imaging have significant application value.

Claims (7)

1. structure is suc as formula the europium complex shown in the I:
Figure F2007101189773C00011
Wherein, among the formula I, R 1, R 2Be that carbonatoms is 1 to 4 alkyl, R 3, R 4Be methyl or H, R 5=R 6=R 7=R 8Be H.
2. the synthetic method of the described europium complex of claim 1 is the compound of structure such as formula III and structure to be dissolved in the organic solvent suc as formula the compound of II react, and obtains the Photostimulable luminescence europium complex of described structure suc as formula I;
Figure F2007101189773C00012
R among its Chinese style II 1, R 2Be that carbonatoms is 1 to 4 alkyl, R 3, R 4Be methyl or H, R 5=R 6=R 7=R 8Be H.
3. synthetic method according to claim 2 is characterized in that: described organic solvent is a kind of or its mixture in tetrahydrofuran (THF), ether, benzene,toluene,xylene, chloroform, the methylene dichloride.
4. synthetic method according to claim 3 is characterized in that: the compound of structure such as formula III and structure are 1: 1 suc as formula the mol ratio of the compound of II.
5. synthetic method according to claim 4 is characterized in that: the compound of structure such as formula III and structure are-10-100 ℃ suc as formula the temperature of reaction of the compound of II.
6. synthetic method according to claim 5 is characterized in that: in the described method, also comprise the organic solvent evaporation in the solution after the reaction end is removed, obtain the europium complex solid of described structure suc as formula I.
7. the application of the described europium complex fluorescence dye of claim 1 in the preparation luminescent material.
CN2007101189773A 2007-06-15 2007-06-15 Europium complex with visible light sensitized light emitting performance and its synthesis process Expired - Fee Related CN101066975B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN2007101189773A CN101066975B (en) 2007-06-15 2007-06-15 Europium complex with visible light sensitized light emitting performance and its synthesis process
PCT/CN2008/000945 WO2008154798A1 (en) 2007-06-15 2008-05-15 N,n-dialkylamidophenyl-dipyrazolyl triazine photosensitive compounds, their europium complexes and their preparation methods

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2007101189773A CN101066975B (en) 2007-06-15 2007-06-15 Europium complex with visible light sensitized light emitting performance and its synthesis process

Publications (2)

Publication Number Publication Date
CN101066975A CN101066975A (en) 2007-11-07
CN101066975B true CN101066975B (en) 2010-06-02

Family

ID=38879690

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007101189773A Expired - Fee Related CN101066975B (en) 2007-06-15 2007-06-15 Europium complex with visible light sensitized light emitting performance and its synthesis process

Country Status (1)

Country Link
CN (1) CN101066975B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008154798A1 (en) * 2007-06-15 2008-12-24 Peking University N,n-dialkylamidophenyl-dipyrazolyl triazine photosensitive compounds, their europium complexes and their preparation methods
CN101701151B (en) * 2008-05-21 2013-03-20 北京大学 Fluorescent nanoparticle and preparation method and application thereof
CN101838476B (en) * 2009-03-18 2013-03-20 北京大学 A type of organic fluorescent dye compound and synthesis method and application thereof
CN101899038B (en) * 2009-05-31 2013-07-31 北京大学 Near-infrared light emitting ionic complex and preparation method thereof
CN102079752B (en) * 2010-12-17 2013-02-20 沈阳化工大学 Synthesis method of rare-earth coordination polymer with functions of mercury ion fluorescence probe
CN102796133B (en) * 2011-05-27 2015-05-20 北京大学 Rare-earth europium complex and application thereof as luminescence material
CN105973472B (en) * 2015-03-12 2019-02-22 北京大学 A kind of near-infrared fluorescent temperature sensing method and material

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1477175A (en) * 2003-06-03 2004-02-25 北京大学 Beta-diketone ligand and its europium coordination compound and europium coordinationi compound electroluminescence device
CN1834094A (en) * 2006-03-31 2006-09-20 北京大学 Terdentate ligand contg. heteroaryl pyrazole, its Eu complex and electroluminescent element

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1477175A (en) * 2003-06-03 2004-02-25 北京大学 Beta-diketone ligand and its europium coordination compound and europium coordinationi compound electroluminescence device
CN1834094A (en) * 2006-03-31 2006-09-20 北京大学 Terdentate ligand contg. heteroaryl pyrazole, its Eu complex and electroluminescent element

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHI YANG ET AL..A HIGHLY LUMINESCENT EUROPIUM CHOMPLEXSHOWING VISIBLE-LGHT-SENSITIZED REDEMISSION:DIRECT OBSERVATION OF THE SINGLETPATHWAY.ANGEWANDTE CHEMIE INTERNATIONAL EDITION43.2004,435010-5013. *
SERGEY M. BORISOV ET AL..TEMPERATURE-SENSITIVE EUROPIUM(III) BROBES ANDTHEIR USE FOR SIMULTANEOUS LUMINESCENTSENSING OF TEMPERATURE AND OXYGEN.ANALYTICAL CHEMISTRY78 14.2006,78(14),5094-5101.
SERGEY M.BORISOV ET AL..TEMPERATURE-SENSITIVE EUROPIUM(III) BROBES ANDTHEIR USE FOR SIMULTANEOUS LUMINESCENTSENSING OF TEMPERATURE AND OXYGEN.ANALYTICAL CHEMISTRY78 14.2006,78(14),5094-5101. *

Also Published As

Publication number Publication date
CN101066975A (en) 2007-11-07

Similar Documents

Publication Publication Date Title
CN101066975B (en) Europium complex with visible light sensitized light emitting performance and its synthesis process
US5503770A (en) Fluorescent compound suitable for use in the detection of saccharides
CN107253965B (en) FRET molecule and its synthetic method of the one kind based on fluorine boron pyrroles and cumarin
Yu et al. Photophysical properties of a series of high luminescent europium complexes with fluorinated ligands
Yuan et al. Light Harvesting and Efficient Energy Transfer in Dendritic Systems: New Strategy for Functionalized Near‐Infrared BF2‐Azadipyrromethenes
Zhou et al. Phenothiazine and diphenylsulfone-based donor–acceptor π-systems exhibiting remarkable mechanofluorochromism
Tan et al. Carbazole-based highly solid-state emissive fluorene derivatives with various mechanochromic fluorescence characteristics
CN100532378C (en) Light-sensitive luminous europium complex and light-sensitive ligand molecule and their synthesizing method
CN107602542A (en) A kind of organic compound containing dibenzo hexatomic ring and its application
Qu et al. The Aggregation Regularity Effect of Multiarylpyrroles on Their Near‐Infrared Aggregation‐Enhanced Emission Property
Wang et al. Tetraphenylethene-functionalized diketopyrrolopyrrole solid state emissive molecules: enhanced emission in the solid state and as a fluorescent probe for cyanide detection
CN101838476B (en) A type of organic fluorescent dye compound and synthesis method and application thereof
CN106905355A (en) Pyrroles's sensitising agent of one class near-infrared iodo fluorine boron two and preparation method thereof
CN113387905A (en) Organic room temperature phosphorescent material, preparation method and application
CN111253338B (en) Efficient organic near-infrared fluorescent material and preparation and application thereof
WO2021068511A1 (en) Synthesis and photoelectric property research of carbazole room-temperature phosphorescent material containing s/se/te heavy atoms
CN115627082B (en) D-A-pi-A type benzothiadiazole functional dye and preparation method and application thereof
Shimomura et al. Push‐Pull Bridged Distyrylbenzene with Highly Bright Solid‐State Red‐Orange Aggregation‐Induced Emission
CN104177389A (en) Rare-earth complex capable of being excited under different concentration conditions to generate high-efficiency rare-earth luminescence
CN101899038B (en) Near-infrared light emitting ionic complex and preparation method thereof
CN109232621B (en) Preparation method of amino-substituted aza-fluoro-boron fluorescent near-infrared dye
Cavazzini et al. Intimately bound coumarin and bis (alkylaminostyryl) benzene fragments: synthesis and energy transfer
CN101081847B (en) Method for synthesizing N,N-dialkylamine phenyl-dipyrazole triazine structural light-sensitive molecule
CN112175607B (en) Organic room temperature phosphorescent material and preparation method and application thereof
Xu et al. Synthesis and properties of D-π-A triphenylamine derivatives with solvatochromism and bioimaging application

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: BEIJING NACAI MATERIAL TECHNOLOGY CO., LTD.

Free format text: FORMER OWNER: PEKING UNIVERSITY

Effective date: 20121203

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 100871 HAIDIAN, BEIJING TO: 102600 DAXING, BEIJING

TR01 Transfer of patent right

Effective date of registration: 20121203

Address after: 102600, 604, building 13, building 3, Xinghua Road (two section), Xinghua Town, Daxing District, Beijing, China. Room 6

Patentee after: Beijing nano material technology Co., Ltd.

Address before: 100871 Haidian District the Summer Palace Road,, No. 5, Peking University

Patentee before: Peking University

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20100602

Termination date: 20150615

EXPY Termination of patent right or utility model